Trial intelligence / Profile preview

Levodopa for naming performance in aphasia

NCT00102869Phase 4Completed

Sponsor
Universitätsklinikum Münster
Start
Jan 2005
Primary completion
Feb 2007
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of levodopa in aphasia, sponsored by Universitätsklinikum Münster. Started Jan 2005; status: completed.

02

Drugs

levodopa
03

Conditions

aphasia

Beyond the preview

Go deeper on NCT00102869.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00102869.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call